Bernstein Karen 4
4 · Ovid Therapeutics Inc. · Filed May 18, 2021
Insider Transaction Report
Form 4
Bernstein Karen
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-05-17+1,750→ 1,750 totalExercise: $3.67Exp: 2031-05-16→ Common Stock (1,750 underlying)
Footnotes (1)
- [F1]The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date.